Loading company…
REV-MED develops therapeutic laser devices and systems for processing autologous biological materials.
Founded in 2009 and based in Seongnam, South Korea, REV-MED develops therapeutic lasers and autologous biological systems. Its products include Tricell PRP, Tricell BMC, Hithera4.0, and Duocell SVF Kit. The company established the REV-MED Stem Cell Institute in 2018 and obtained EN ISO 13485:2018 and Hilthera 4.0 CE certification in 2020.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in